| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.007 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.092 | 0.008 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.16 | 0.009 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.01 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.01 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |